Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using its IMPACT platform, the company is addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements of biologics drug discovery - structural biology, protein engineering and translational immunology- to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has an emerging pipeline of novel biologics to address adaptive immune system dysregulation to treat autoimmune diseases.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
02/09/22	$101,000,000	Series A	Boxer Capital GV Polaris Partners Samsara BioCapital Timothy Springer	undisclosed
12/04/23	$121,000,000	Series B	Alexandria Venture Investments Amgen Ventures Bessemer Venture Partners Boxer Capital Codon Capital Gaingels GC&H Investments GV Lightspeed Venture Partners Polaris Partners Samsara BioCapital Timothy Springer	undisclosed